These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Evaluation of the therapeutic effects of secondary antitubercular agents]. Watanabe S, Nosaki M, Iwasaki M, Hamano S, Furuya Y. Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119 [No Abstract] [Full Text] [Related]
6. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics. Zierski M. Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863 [No Abstract] [Full Text] [Related]
7. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests]. Tsukamura M. Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456 [No Abstract] [Full Text] [Related]
9. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs]. Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M. Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711 [No Abstract] [Full Text] [Related]
11. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis]. Utkin VV, Rudoĭ NM. Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. Prasad R, Verma SK, Sahai S, Kumar S, Jain A. Indian J Chest Dis Allied Sci; 2006 Dec; 48(3):183-6. PubMed ID: 18610675 [Abstract] [Full Text] [Related]
13. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis]. Bialik IB. Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728 [No Abstract] [Full Text] [Related]
14. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis]. Mamolat AS, Bialik IB, Khutorskaia VD. Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127 [No Abstract] [Full Text] [Related]
15. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients. Mital OP, Agarwala MC, Singh SK. Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543 [No Abstract] [Full Text] [Related]
16. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs]. Uvarova OA, Zemskova ZS, Stukalova BIa, Afanas'eva IuP. Farmakol Toksikol; 1967 Oct; 30(4):474-7. PubMed ID: 4877410 [No Abstract] [Full Text] [Related]
17. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis]. Kaminskaia AA, Utkin VV, Korotaev GA, Golitsina LV. Probl Tuberk; 1967 Oct; 45(5):29-33. PubMed ID: 5617941 [No Abstract] [Full Text] [Related]
18. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis. Ando M. Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943 [No Abstract] [Full Text] [Related]
19. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences. de Kantor IN, Barrera L. Medicina (B Aires); 2007 Jan; 67(3):231-7. PubMed ID: 17628909 [Abstract] [Full Text] [Related]
20. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital]. Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ. Probl Tuberk; 1974 Jan; (10):17-9. PubMed ID: 4370967 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]